BackBIO 150 – Exam 3: Principles of Disease, Immunity, and Immune Disorders
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Principles of Disease & Epidemiology
Key Definitions
Pathology: Study of disease.
Etiology: Cause of a disease.
Pathogenesis: Development of disease.
Infection: Invasion or colonization of the body by pathogens.
Disease: Abnormal state in which the body is not performing normal functions.
Epidemiology: Study of where and when diseases occur and how they spread in populations.
Morbidity rate: Number of people affected relative to total population in a given time period.
Mortality rate: Number of deaths from a disease relative to the population in a given time.
Symbiotic Relationships
Type | Who Benefits? | Example |
|---|---|---|
Commensalism | One organism benefits; other is unaffected | Staphylococcus epidermidis on skin |
Mutualism | Both organisms benefit | E. coli in large intestine |
Parasitism | One benefits at the expense of the other | Influenza viruses on host cells |
Koch's Postulates
The same pathogen must be present in every case of the disease.
The pathogen must be isolated from the diseased host and grown in pure culture.
The pathogen from the pure culture must cause the disease when inoculated into a healthy, susceptible lab animal.
The pathogen must be isolated from the inoculated animal and shown to be the original organism.
Key point: Koch's postulates establish the etiology of infectious disease, which is essential for treatment and prevention.
Communicable vs. Noncommunicable Diseases
Communicable disease: Can be spread from one host to another (directly or indirectly).
Contagious disease: Communicable disease that is easily spread (e.g., influenza).
Noncommunicable disease: Not spread from host to host; caused by opportunistic pathogens or environmental sources (e.g., tetanus from soil).
Frequency of Disease Occurrence
Term | Definition | Example |
|---|---|---|
Sporadic | Occurs occasionally in isolated cases | Tetanus in the US |
Endemic | Constantly present in a population/region | Common cold |
Epidemic | Sudden increase above expected level in a region | Influenza outbreak |
Pandemic | Worldwide epidemic | COVID-19, influenza 1918 |
Incidence vs. Prevalence
Incidence: Number of new cases in a given time period.
Prevalence: All cases (old + new) at a specific point in time.
Severity/Duration of Disease
Type | Definition | Example |
|---|---|---|
Acute | Develops rapidly; short duration | Flu |
Chronic | Develops slowly; long duration | TB, Lyme disease |
Subacute | Between acute and chronic | — |
Latent | Causative agent remains inactive for a time before becoming active | Shingles/chickenpox |
Predisposing Factors
Gender
Inherited traits (e.g., sickle cell gene)
Climate and weather
Lack of vaccination
Fatigue
Age
Lifestyle and nutrition
Chemotherapy
Stages of Disease
Stage | Description |
|---|---|
Incubation period | Time between infection and first symptoms; pathogen multiplying but no signs/symptoms yet |
Prodromal period | Mild, early signs/symptoms begin; highly contagious |
Period of illness | Most severe signs and symptoms; peak pathogen numbers |
Period of decline | Signs/symptoms subside; still vulnerable to secondary infections |
Period of convalescence | Body returns to pre-disease state; recovery |
Reservoirs and Transmission
Human reservoirs: Carriers may have inapparent infections or latent diseases.
Animal reservoirs (zoonoses): Diseases transmitted from animals to humans (e.g., rabies, Lyme disease, West Nile).
Nonliving reservoirs: Soil and water.
Vectors
Type | Description | Example |
|---|---|---|
Mechanical | Arthropod carries pathogen on its feet/body (no reproduction in vector) | Housefly carrying Salmonella |
Biological | Pathogen reproduces inside the arthropod; transmitted via bite or feces | Mosquito transmitting malaria |
Modes of Transmission
Type | Description | Example |
|---|---|---|
Direct contact | Close association between infected and susceptible host | Kissing, sexual contact |
Congenital (vertical) | Mother to fetus/newborn | HIV, rubella, syphilis |
Indirect contact | Spread via fomite (nonliving object) | Doorknob, shared needles |
Droplet | Airborne droplets <1 meter | Sneezing, coughing |
Vehicle – Airborne | Dust or droplet nuclei >1 meter | TB, measles |
Vehicle – Waterborne | Contaminated water | Cholera, Giardia |
Vehicle – Foodborne | Contaminated food | Salmonella, E. coli O157 |
Healthcare-Associated Infections (HAIs)
Also called nosocomial infections – acquired while receiving treatment in a healthcare facility.
Require three factors: microorganisms in the healthcare environment, compromised host, and chain of transmission.
Epidemiology
CDC collects and analyzes US epidemiological information; publishes the Morbidity and Mortality Weekly Report (MMWR).
Emerging infectious diseases: new, increasing in incidence, or showing potential to increase – most are zoonotic, viral, and vector-borne.
Microbial Mechanisms of Pathogenicity
Key Terms
Pathogenicity: Ability of a microbe to cause disease.
Virulence: Degree of pathogenicity; how severe or damaging.
Virulence factors: Structures or products that allow a pathogen to cause infection.
ID50: Infectious dose for 50% of the test population.
LD50: Lethal dose that kills 50% of the test population.
Adhesin (ligand): Surface molecule on pathogen that binds to host cell receptor.
Portals of Entry
Mucous membranes: Respiratory, GI, genitourinary tracts, conjunctiva (most common entry).
Skin: Requires a break or wound; few pathogens penetrate intact skin.
Parenteral route: Deposited directly into tissues via puncture, bite, surgery, or injection.
During pregnancy/birth: Mother to fetus (e.g., HIV, rubella).
Note: The greatest number of pathogens enter through the respiratory system.
Microbial Adherence Mechanisms
Adhesion requires a lock-and-key match: adhesin (ligand) on pathogen binds to receptor on host cell surface.
Structures used for adhesion include fimbriae (pili), capsules, and viral spikes.
Capsules & Cell Wall Components
Capsules: Prevent phagocytosis (e.g., Streptococcus pneumoniae).
M protein: (Streptococcus pyogenes) resists phagocytosis.
Mycolic acid: (Mycobacterium tuberculosis) resists digestion inside phagocytes.
Gram-negative outer membrane: Protects from lysozyme and complement.
Exoenzymes and Their Effects
Enzyme | What It Does | Pathogen |
|---|---|---|
Hyaluronidase | Breaks down hyaluronic acid; allows pathogen to spread | Streptococcus, Staphylococcus, Clostridium |
Collagenase | Breaks down collagen in connective tissue | Clostridium perfringens |
Coagulase | Converts fibrinogen to fibrin; bacteria hide in clot | Staphylococcus aureus |
Streptokinase | Dissolves fibrin clots; allows bacteria to spread | Streptococcus |
IgA protease | Destroys IgA antibodies on mucous membranes | Neisseria, H. influenzae |
Mechanisms to Avoid Phagocytosis
Capsule formation
Antigenic variation (e.g., Neisseria gonorrhoeae, Influenza)
Intracellular survival (e.g., Mycobacterium tuberculosis, Listeria, Legionella)
Invasins: induce host cell membrane ruffling (e.g., Salmonella)
Direct Damage by Pathogens
Disrupt host cell function
Use host cell nutrients
Produce toxic waste products
Multiply inside host cells causing lysis
Siderophores: steal iron from host proteins
Exotoxins vs. Endotoxins
Property | Exotoxins | Endotoxins |
|---|---|---|
Bacterial source | Gram+ and Gram- | Gram- only |
Chemical nature | Proteins (A-B structure) | Lipopolysaccharide (LPS) – lipid A |
Relation to organism | Secreted by living cells | Part of outer membrane; released on cell death |
Heat stability | Unstable (destroyed at 60–80°C) | Stable (withstands autoclaving at 121°C) |
Toxicity | High (toxic in minute amounts) | Low (requires high doses) |
Fever-producing | Usually no | Yes |
Toxoid formation | Yes (can be inactivated for vaccines) | No |
Immune response | Stimulates antitoxin antibodies | Poor stimulation of antitoxins |
Representative diseases | Tetanus, botulism, diphtheria, gas gangrene | Typhoid fever, UTIs, meningococcal meningitis |
Types of Exotoxins
Type | Mechanism | Example |
|---|---|---|
A-B toxins | B (binding) subunit attaches to host; A (active) subunit disrupts function | Cholera, diphtheria, botulinum toxins |
Membrane-disrupting | Form pores in cell membrane causing lysis | Streptolysin, leukocidins |
Superantigens | Overstimulate T cells → massive cytokine release | Toxic shock syndrome toxin (TSST-1), staph enterotoxins |
Cytopathic Effects (CPE) of Viruses
Halts normal cell metabolism
Inclusion bodies (e.g., Negri bodies in rabies)
Syncytium formation (e.g., HIV, measles)
Induces chromosomal and antigenic changes
Loss of contact inhibition (may lead to cancer)
Innate Immunity: Nonspecific Defenses
Innate vs. Adaptive Immunity
Type | Also Called | Key Features |
|---|---|---|
Innate | Non-specific | Born with it; same response to all pathogens; 1st & 2nd line of defense |
Adaptive | Specific / Acquired | Developed after exposure; unique response per microbe; 3rd line; uses B & T cells |
PAMPs and PRRs
PAMPs: Pathogen-Associated Molecular Patterns (e.g., peptidoglycan, LPS, dsRNA)
PRRs: Pattern Recognition Receptors on phagocytes, dendritic cells, endothelial cells
TLRs: Toll-Like Receptors, a type of PRR that triggers immune activation
First Line of Defense – Physical & Chemical Barriers
Physical barriers: Skin (keratinized), hair follicles, mucous membranes, cilia, normal microbiota
Chemical barriers: Sebum, lactic acid, lysozyme (tears, saliva), stomach acid, digestive enzymes, acidic vaginal pH, antimicrobial chemicals in semen
Second Line of Defense – Internal Defenses
Phagocytic cells: Survey tissues, ingest and destroy microbes
Steps of phagocytosis:
Chemotaxis
Adherence
Ingestion
Phagolysosome formation
Digestion
Discharge
Natural Killer (NK) cells: Kill virus-infected and cancer cells by releasing perforin and granzymes
Inflammatory Response
Non-specific local response to tissue damage or pathogen entry
Cardinal signs: Rubor (redness), Calor (heat), Tumor (swelling), Dolor (pain), Loss of function
Steps: Injury/Immediate → Vascular Reactions → Edema/Pus Formation → Resolution/Scar Formation
Fever
Systemic response triggered by pyrogens (e.g., LPS)
Benefits: Inhibits microbe multiplication, decreases iron availability, increases metabolism and phagocytosis
Complement System
Over 30 proteins in plasma; activated in a cascade
Outcomes: Cell lysis (MAC), opsonization, inflammation
Other Antimicrobial Substances
Substance | Mechanism |
|---|---|
Interferons (IFNs) | Induce antiviral proteins in neighboring cells; enhance phagocytosis |
Iron-binding proteins | Decrease iron availability to microbes |
Antimicrobial peptides | Lyse bacterial cell membranes |
Adaptive Immunity: Specific Defenses
Types of T Cells & Their Roles
T Cell Type | Surface Marker | MHC Required | Role |
|---|---|---|---|
Helper T (TH) | CD4 | MHC II | Activate cytotoxic T cells and B cells; secrete cytokines |
Cytotoxic T (TC/CTL) | CD8 | MHC I | Kill virus-infected and cancer cells |
Regulatory T (Treg) | CD4 | MHC II | Suppress immune response; prevent autoimmunity |
Memory T cells | CD4 or CD8 | — | Rapid response upon re-exposure |
MHC I vs. MHC II
Feature | MHC I | MHC II |
|---|---|---|
Found on | All nucleated cells | APCs only (macrophages, dendritic cells, B cells) |
Presents to | Cytotoxic T cells (CD8+) | Helper T cells (CD4+) |
Source of antigen | Intracellular | Extracellular |
Cell-Mediated Immunity (CMI)
Carried out by cytotoxic T cells (TC cells)
Targets: virus-infected cells, cancer cells, transplanted cells
Mechanism: TC cell binds via CD8 + MHC I + antigen, releases perforin and granzymes → apoptosis
Antibody-Mediated (Humoral) Immunity
Carried out by B cells → plasma cells secrete antibodies
Most B cell activation requires Helper T2 (TH2) cells
B cells have MHC II on their surface
Memory B cells enable rapid secondary response
Antibody (Immunoglobulin) Structure
Y-shaped protein; 2 heavy + 2 light chains
FAb regions: variable, antigen-binding
Fc region: constant, binds immune cells, triggers complement
Classes of Immunoglobulins
Class | Structure | Key Features |
|---|---|---|
IgM | Pentamer | First produced; complement activator; agglutination |
IgG | Monomer | Most abundant; crosses placenta; opsonization |
IgA | Dimer | Secretions (tears, saliva, milk); mucosal defense |
IgE | Monomer | Allergic reactions; histamine release |
IgD | Monomer | On naive B cells; antigen receptor |
Primary vs. Secondary Immune Response
Feature | Primary | Secondary |
|---|---|---|
Trigger | First exposure | Re-exposure |
Speed | Slow (days–weeks) | Fast (hours–days) |
Magnitude | Low antibody titer | High antibody titer |
Antibody class | IgM first, then IgG | Mostly IgG |
Cells involved | Naive B + TH cells | Memory B cells |
Duration | Short-lived | Long-lasting |
Mechanisms of Antibody Action
Opsonization: Antibodies coat microbe, enhancing phagocytosis
Agglutination: Cross-link antigens into clumps
Neutralization: Block surface receptors on viruses/toxins
Antitoxin: Neutralizes bacterial exotoxins
Complement activation: Antibody-antigen complex triggers complement cascade
Types of Adaptive Immunity
Type | How Acquired | Memory? | Example |
|---|---|---|---|
Natural Active | Infection; body makes antibodies | Yes | Flu infection |
Natural Passive | Mother to fetus/infant | No | IgG via placenta; IgA via milk |
Artificial Active | Vaccination | Yes | MMR vaccine |
Artificial Passive | Injection of preformed antibodies | No | Rabies immune globulin |
Active vs. Passive Immunity
Feature | Active | Passive |
|---|---|---|
Antigen exposure | Yes | No |
Immune memory | Yes | No |
Onset | Days to weeks | Immediate |
Duration | Long-lasting | Short-lived |
Vaccines
Antigen or antigen mixture used to induce artificial active immunity
Provokes primary response; memory cells formed
Herd immunity: immunity in most of the population limits spread
Applications of Immunology
Biochemical Tests
Based on enzyme-mediated metabolic reactions
Physiological reactions reveal enzyme systems; visualized by color change
Serology
In vitro diagnostic testing of serum
Detects, identifies, and quantifies antibodies or antigens
Principle: unknown antibody detected using known antigen, or vice versa
Agglutination and Precipitation
Test | Antigen Type | Description | Example |
|---|---|---|---|
Agglutination | Whole cells | Antibody-mediated clumping | Blood typing |
Precipitation | Soluble molecules | Antigen-antibody complexes in solution | RPR test |
Western Blot
Proteins separated by gel electrophoresis, detected by antibodies
Used for HIV verification
Neutralization Reactions
Viral hemagglutination: viruses agglutinate RBCs
Hemagglutination inhibition: patient serum neutralizes virus, preventing agglutination
Molecular/Genotypic Methods
PCR: Amplifies DNA/RNA; highly sensitive
Hybridization: Probes bind specific sequences for identification
Vaccine Types
Type | Description |
|---|---|
Inactivated | Killed microorganisms; not infectious |
Attenuated (Live) | Living, non-virulent strains |
Toxoid | Chemically modified exotoxin |
Recombinant DNA | Gene cloned and expressed in another microbe |
Adjuvants: Chemical additives to improve vaccine effectiveness (e.g., alums, monophosphoryl lipid A)
Immune Disorders
Hypersensitivity / Immunopathology
Immunopathology: Study of disease states from overreactivity (allergy, autoimmunity) or underreactivity (immunodeficiency)
The Four Types of Hypersensitivity
Type | Name | Onset | Ig Involved | Mechanism | Examples |
|---|---|---|---|---|---|
I | Anaphylactic / Immediate | <30 min | IgE | IgE binds mast cells → degranulation | Hay fever, asthma, anaphylaxis |
II | Cytotoxic | 5–12 hrs | IgG, IgM | Ab binds cell surface → complement → lysis | Transfusion reactions, Rh incompatibility |
III | Immune Complex | 3–8 hrs | IgG, IgM, IgA | Immune complexes lodge in tissues → complement → tissue damage | Serum sickness, SLE, RA |
IV | Delayed / Cell-Mediated | 24–48 hrs | None (T cells) | CTLs and macrophages cause tissue damage | Contact dermatitis, TB test, graft rejection |
Type I – Anaphylactic (IgE-Mediated Immediate)
Sensitization: Allergen exposure → IgE produced → binds mast cells
Provocation: Allergen re-exposure → mast cell degranulation → histamine, leukotrienes, prostaglandins released
Effects: Vasodilation, smooth muscle contraction, increased mucus, skin manifestations
Atopic diseases: Hay fever, asthma, eczema, food/drug allergies
Systemic anaphylaxis: Rapid, life-threatening; triggers include bee venom, antibiotics
Treatment: Avoidance, steroids, monoclonal antibodies, cromolyn, antihistamines, desensitization
Type II – Cytotoxic (IgG & IgM)
Antibodies bind cell surface antigens → complement activation → cell lysis
Blood Type | Antigens on RBC | Antibodies in Serum |
|---|---|---|
A | A | Anti-B |
B | B | Anti-A |
AB | A and B | Neither |
O | None | Anti-A and Anti-B |
Transfusion reactions: Wrong blood type → hemolysis, shock, kidney failure
Hemolytic disease of the newborn: Rh- mother, Rh+ fetus; prevented by RhoGAM
Type III – Immune Complex
Antibody + excess soluble antigen → large complexes lodge in tissues → complement activation → tissue damage
Examples: Serum sickness, Arthus reaction, SLE, rheumatoid arthritis
Type IV – Delayed/Cell-Mediated (T Cells)
T cells respond to antigens on self or transplanted tissues
Symptoms arise 24–48 hours after exposure
Examples: Contact dermatitis, TB skin test, graft rejection, some chronic diseases
Autoimmunity
Immune system attacks self-antigens (autoantibodies or T cells)
Systemic (multiple organs) or organ-specific
Disease | Target | Hypers. Type | Characteristics |
|---|---|---|---|
Systemic lupus erythematosus (SLE) | Systemic | III | Antibodies against RBCs, WBCs, platelets, DNA |
Rheumatoid arthritis | Joints | II, III, IV | Vasculitis, antibodies against other antibodies |
Graves' disease | Thyroid | III | Antibodies against TSH receptors |
Myasthenia gravis | Muscle | III | Antibodies against acetylcholine receptors |
Type I diabetes | Pancreas | IV | T cells attack insulin-producing cells |
Multiple sclerosis | Myelin | II, IV | T cells and antibodies destroy neurons |
Immunodeficiency Diseases
Primary (Congenital)
Condition | What's Deficient | Result |
|---|---|---|
DiGeorge syndrome | T cells (thymus absent/underdeveloped) | Recurrent fungal, protozoan, viral infections |
ADA deficiency | T cell development blocked | Recurrent infections |
X-linked SCID | T and B cells | Severe combined immunodeficiency |
Congenital agammaglobulinemia | B cells/antibodies absent | Recurrent bacterial infections |
Hypogammaglobulinemia | Low immunoglobulin/B cells | Recurrent bacterial infections |
Secondary (Acquired)
Caused by infection, metabolic disease, chemotherapy, radiation
AIDS: HIV infects T helper cells, monocytes, macrophages, APCs; depletion of T helper cells impairs immune responses, leading to cancers and opportunistic infections
Additional info: This guide covers core concepts from BIO 150 Exam 3, including disease principles, epidemiology, mechanisms of pathogenicity, innate and adaptive immunity, immunological applications, and immune disorders. It is suitable for exam preparation and review in a college-level microbiology course.